Profile
James R.
Piggott has been Senior Vice President of Pharmaceutical Biology for Lexicon Pharmaceuticals, Inc. since January 2000.
From 1990 to October 1999, he worked at ZymoGenetics, Inc., most recently as Senior Vice President-Research Biology from 1997 to October 1999.
Previously, Dr. Piggott worked at the Smith Kline & French Laboratories Ltd.
and the GD Searle & Co. He received a BA degree and a PhD from Trinity College.
Former positions of James R. Piggott
| Companies | Position | End |
|---|---|---|
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 1999-09-30 |
| LEXICON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of James R. Piggott
| Trinity College Dublin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- James R. Piggott
